Clinical Trial

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

Study acronym: IREN
Recruiting
View on ClinicalTrials.gov →
Summary
Multicenter, observational, prospective study of molecular profiling in advanced and aggressive endometrial cancer patients and 1-st line treatment approaches in Russian Federation
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-06-26; most recent amendment 2026-07-08.
Status change: Not Yet Recruiting → Recruiting 2025-08-13
Trial Details
NCT Number NCT07041606
Lead Sponsor AstraZeneca
Conditions Endometrial Cancer
Enrollment 500 participants
Start Date 2025-06-24
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-10